In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development
Obinna C. Ubah, Andrew J. Porter, and Caroline J. Barelle
Journal of Immunology Research 2020; doi: 10.1155/2020/7283239